UBS Group’s Janux Therapeutics JANX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.06M Sell
219,806
-370,254
-63% -$5.08M ﹤0.01% 4582
2025
Q4
$8.14M Buy
590,060
+199,703
+51% +$4.7M ﹤0.01% 3512
2025
Q3
$9.54M Buy
390,357
+97,824
+33% +$2.38M ﹤0.01% 3341
2025
Q2
$6.76M Sell
292,533
-195,947
-40% -$5.16M ﹤0.01% 3550
2025
Q1
$13.2M Buy
488,480
+263,390
+117% +$9.93M ﹤0.01% 2769
2024
Q4
$12.1M Buy
225,090
+170,896
+315% +$9.04M ﹤0.01% 2851
2024
Q3
$2.46M Buy
54,194
+3,326
+7% +$145K ﹤0.01% 3796
2024
Q2
$2.13M Buy
50,868
+28,664
+129% +$1.35M ﹤0.01% 3716
2024
Q1
$836K Buy
+22,204
New +$484K ﹤0.01% 4744
2023
Q2
Sell
-841
Closed -$10.2K 9264
2023
Q1
$10.2K Buy
841
+628
+295% +$10.5K ﹤0.01% 7601
2022
Q4
$2.81K Buy
+213
New +$3.12K ﹤0.01% 9622
2022
Q2
Sell
-3,500
Closed -$50K 10625
2022
Q1
$50K Sell
3,500
-185
-5% -$3.03K ﹤0.01% 6497
2021
Q4
$73K Buy
3,685
+185
+5% +$3.88K ﹤0.01% 6574
2021
Q3
$76K Buy
3,500
+3,147
+892% +$90.5K ﹤0.01% 6025
2021
Q2
$9K Buy
+353
New +$7.86K ﹤0.01% 8142

Other funds holding JANX